Skyhawk Therapeutics


At Skyhawk Therapeutics we invent small molecules using proprietary kinetic, structural and computational models that correct RNA splicing and mis-spicing. Our small molecule platform accelerates drug development across a broad range of disease types.

Industries

Employees

51-200

Links


Org chart

Bill Haney
CEO & Chairman of the Board
Collapse
Terrance Connolly
Chief Operating Officer
John McKeague
Senior Vice President Legal
Maggie Beaudoin
VP Of Finance
Douglas V Faller
Chief Medical Officer
Kyle Dow
Vice President Corporate Development
Sergey Paushkin
Chief Scientific Officer

Board & advisors



Offices